Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels.
about
Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing.Global assays and the management of oral anticoagulation.Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offsImpact of Non-Vitamin K Antagonist Oral Anticoagulants From a Basic Science Perspective.Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutation.Thrombin generation in low plasma volumes.
P2860
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Bleeding risk in warfarinized ...... ffect of low factor IX levels.
@en
Bleeding risk in warfarinized ...... ffect of low factor IX levels.
@nl
type
label
Bleeding risk in warfarinized ...... ffect of low factor IX levels.
@en
Bleeding risk in warfarinized ...... ffect of low factor IX levels.
@nl
prefLabel
Bleeding risk in warfarinized ...... ffect of low factor IX levels.
@en
Bleeding risk in warfarinized ...... ffect of low factor IX levels.
@nl
P2093
P2860
P50
P356
P1476
Bleeding risk in warfarinized ...... effect of low factor IX levels
@en
P2093
P2860
P304
P356
10.1111/JTH.12244
P577
2013-06-01T00:00:00Z